Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?

Background and Objectives: Reporting adverse drug reactions (ADRs) associated with drug use is an important factor in patient safety. Majority of ADRs are preventable through improved prescribing and monitoring. Endocrinologists prescribe drugs with actions on almost all organs and for relatively lo...

Full description

Bibliographic Details
Main Authors: Pramod Kumar Sharma, Surjit Singh, Puneet Dhamija
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=3;spage=343;epage=347;aulast=Sharma
id doaj-06cfb0b3a72d48e0b86fe80c1c1abd9b
record_format Article
spelling doaj-06cfb0b3a72d48e0b86fe80c1c1abd9b2020-11-24T22:25:07ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102230-95002016-01-0120334334710.4103/2230-8210.180007Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?Pramod Kumar SharmaSurjit SinghPuneet DhamijaBackground and Objectives: Reporting adverse drug reactions (ADRs) associated with drug use is an important factor in patient safety. Majority of ADRs are preventable through improved prescribing and monitoring. Endocrinologists prescribe drugs with actions on almost all organs and for relatively longer durations. ADR are expected following the use of these drugs. Pharmacovigilance is the study of drug-related adverse effects aimed at protecting patients and public from drug-related harms. The concept of pharmacovigilance is relatively new in India, and this survey is an attempt to explore awareness among doctors of an establishing institution of national importance. Materials and Methods: The survey was conducted on faculty and resident doctors by administering a written structured questionnaire in a voluntary manner. The questionnaire contained questions meant to evaluate their awareness, understanding, and misconception about ADR reporting. Identity of the responder was kept confidential. Results: A total of 106 (faculty = 56; residents = 50) participated in survey. The most common cause cited for not reporting an ADR was “do not know how to report” by 64.15%. Majority of them (64%) had no information about the Pharmacovigilance Programme of India (PvPI), and only few (8.5%) had actually reported or published an ADR. Interpretation and Conclusions: ADRs are major public health problem that needs to be addressed at all levels of health care. High index of clinical suspicion are crucial for their timely detection and management. Various educational interventions have shown to improve medical professionals' awareness, understanding about ADRs and in their reporting behavior. PvPI is an important initiative toward ensuring patient safety.http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=3;spage=343;epage=347;aulast=SharmaAdverse drug reactionpharmacovigilancePharmacovigilance Programme of India
collection DOAJ
language English
format Article
sources DOAJ
author Pramod Kumar Sharma
Surjit Singh
Puneet Dhamija
spellingShingle Pramod Kumar Sharma
Surjit Singh
Puneet Dhamija
Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?
Indian Journal of Endocrinology and Metabolism
Adverse drug reaction
pharmacovigilance
Pharmacovigilance Programme of India
author_facet Pramod Kumar Sharma
Surjit Singh
Puneet Dhamija
author_sort Pramod Kumar Sharma
title Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?
title_short Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?
title_full Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?
title_fullStr Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?
title_full_unstemmed Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?
title_sort awareness among tertiary care doctors about pharmacovigilance programme of india: do endocrinologists differ from others?
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Endocrinology and Metabolism
issn 2230-8210
2230-9500
publishDate 2016-01-01
description Background and Objectives: Reporting adverse drug reactions (ADRs) associated with drug use is an important factor in patient safety. Majority of ADRs are preventable through improved prescribing and monitoring. Endocrinologists prescribe drugs with actions on almost all organs and for relatively longer durations. ADR are expected following the use of these drugs. Pharmacovigilance is the study of drug-related adverse effects aimed at protecting patients and public from drug-related harms. The concept of pharmacovigilance is relatively new in India, and this survey is an attempt to explore awareness among doctors of an establishing institution of national importance. Materials and Methods: The survey was conducted on faculty and resident doctors by administering a written structured questionnaire in a voluntary manner. The questionnaire contained questions meant to evaluate their awareness, understanding, and misconception about ADR reporting. Identity of the responder was kept confidential. Results: A total of 106 (faculty = 56; residents = 50) participated in survey. The most common cause cited for not reporting an ADR was “do not know how to report” by 64.15%. Majority of them (64%) had no information about the Pharmacovigilance Programme of India (PvPI), and only few (8.5%) had actually reported or published an ADR. Interpretation and Conclusions: ADRs are major public health problem that needs to be addressed at all levels of health care. High index of clinical suspicion are crucial for their timely detection and management. Various educational interventions have shown to improve medical professionals' awareness, understanding about ADRs and in their reporting behavior. PvPI is an important initiative toward ensuring patient safety.
topic Adverse drug reaction
pharmacovigilance
Pharmacovigilance Programme of India
url http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=3;spage=343;epage=347;aulast=Sharma
work_keys_str_mv AT pramodkumarsharma awarenessamongtertiarycaredoctorsaboutpharmacovigilanceprogrammeofindiadoendocrinologistsdifferfromothers
AT surjitsingh awarenessamongtertiarycaredoctorsaboutpharmacovigilanceprogrammeofindiadoendocrinologistsdifferfromothers
AT puneetdhamija awarenessamongtertiarycaredoctorsaboutpharmacovigilanceprogrammeofindiadoendocrinologistsdifferfromothers
_version_ 1725759252340932608